Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

待确认 10 由老谈发布于 2026/4/8 21:35:24

DOI:10.1016/s0140-6736(24)02551-0
作者：Bruno Sangro, Masatoshi Kudo, Joseph P Erinjeri, Shukui Qin, Zhenggang Ren, Stephen L Chan, Yasuaki Arai, Jeong Heo, Anh Mai, Jose Escobar, Yamil Alonso Lopez Chuken, Jung-Hwan Yoon, Won Young Tak, Va
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundTransarterial chemoembolisation (TACE) is standard of care for patients with unresectable hepatocellular carcinoma that is amenable to embolisation; however, median progression-fre

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

2026-04-08

vwan

da2c9902334f11f19b9434735aa3bc31.pdf

2026-04-08

Book学术机器人

2026/4/8 21:35:24 未找到该文献，机器人已退出，请等待人工下载

2026/4/8 21:35:24 Book学术AI机器人收到请求，开始寻找文献

2026/4/8 21:35:24 已向机器人发送请求

2026-04-08

老谈发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Microenvironment Engineering Vinylene-Linked Covalent Organic Frameworks for Highly Efficient CO2 Photoreduction.